论文信息 - FDA Approval Summary: Ado-Trastuzumab Emtansine for the Adjuvant Treatment of HER2-positive Early Breast Cancer - 字舞流文

FDA Approval Summary: Ado-Trastuzumab Emtansine for the Adjuvant Treatment of HER2-positive Early Breast Cancer

L. Fashoyin-Aje | K. Goldberg | R. Pazdur | B. King-Kallimanis | L. Amiri-Kordestani | R. Sridhara | Shenghui Tang | M. Theoret | A. Ibrahim | J. Beaver | E. Bloomquist | S. Wedam | Xin Gao | Kirsten B. Goldberg